SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-14-001326
Filing Date
2014-05-15
Accepted
2014-05-15 16:12:57
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q biostarpharma10q033114.htm 10-Q 790535
2 EX-31.1 ex31-1.htm EX-31.1 17773
3 EX-31.2 ex31-2.htm EX-31.2 17582
4 EX-32.1 ex32-1.htm EX-32.1 8106
5 EX-32.2 ex32-2.htm EX-32.2 7113
  Complete submission text file 0001185185-14-001326.txt   5651426

Data Files

Seq Description Document Type Size
6 EX-101.INS bspm-20140331.xml EX-101.INS 905047
7 EX-101.SCH bspm-20140331.xsd EX-101.SCH 48053
8 EX-101.CAL bspm-20140331_cal.xml EX-101.CAL 38382
9 EX-101.DEF bspm-20140331_def.xml EX-101.DEF 216070
10 EX-101.LAB bspm-20140331_lab.xml EX-101.LAB 345993
11 EX-101.PRE bspm-20140331_pre.xml EX-101.PRE 221163
Mailing Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046
Business Address NO. 588 SHIJI XI AVENUE XIANYANG, SHAANXI PROVINCE F4 712046 011-86-29-33686638
Biostar Pharmaceuticals, Inc. (Filer) CIK: 0001418133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34708 | Film No.: 14847368
SIC: 2834 Pharmaceutical Preparations